Xuriden

Chemical Nameuridine triacetate
Dosage FormGranules (oral; 2 gm/packet)
Drug ClassMiscellaneous
SystemUrinary, Nervous, Blood
CompanyWellstat Therapeutics
Approval Year2015

Indication

  • To treat patients with hereditary orotic aciduria.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xuriden (uridine triacetate) Prescribing Information 2017Wellstat Therapeutics Corporation, Rockville, MD